Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinomaJames G. Herman, Stephen B. Baylin, Asad Umar et al.|Proceedings of the National Academy of Sciences|1998Cited by 1.9k
Epigenetic Determinants of CancerStephen B. Baylin, Peter A. Jones|Cold Spring Harbor Perspectives in Biology|2016Cited by 1.3k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Stephen B. Baylin et al.|Cancer Discovery|2016Cited by 897
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung CancerMichael J. Topper, Stephen B. Baylin, Michelle Vaz et al.|Cell|2017Cited by 521
Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA HypermethylationKevin Pruitt, Stephen B. Baylin|PLoS Genetics|2006Cited by 382